When evaluating a drug’s potential for market success, it is essential to understand its positioning relative to existing competitors and therapeutic options. However, grasping the nuances of treatment indications and the management of clinical diseases can be complex. Additionally, the number of drugs targeting the same conditions continues to grow, making it increasingly challenging to identify true competitive advantages.
 
We support you in analyzing how a firm's assets are positioned within the broader therapeutic landscape and in assessing their potential to capture and sustain market share.
​